Middle for Drugs within the Public Curiosity Launches Commonsense Science Initiative

164 0
Restoring the Balance Between Innovation and Generic Manufacturing ...

New York, New York–  The Center for Medicine in the Public Interest has launched the Commonsense Science Initiative (CSI) to provide strong, science-based policy, public discussion and public engagement on tobacco harm reduction innovation, primarily focused on the United States but with global reach.   

According to Peter Pitts, President of CMPI and former Associate Commissioner for External Affairs at the Food and Drug Administration noted: John Adams famously said: “Facts are stubborn things; and whatever may be our wishes, our inclinations, or the dictates of our passion, they cannot alter the state of facts and evidence.

**Read CMPI’s Robert Goldberg on “FDA and Media Spreads Fear About Fake Vape-COVID Connection“**

In the same spirit, CSI will promote awareness of bad science and set the record straight about the impact of alternatives to smoking on public health, well-being and the environment.”

As part of that mission CSI will issue rapid response fact sheets and launch a regular blog post on drugwonks.com to call attention to US media coverage of reduced risk smoking alternatives that is incomplete, methodologically flawed, non-reproducible and outright misleading.

The CSI blog will combine original content, summaries of scientific papers, as well as re-publication of articles and speeches given by harm reduction experts.

About CMPI

The Center for Medicine in the Public Interest is a nonprofit, nonpartisan research and educational organization that seeks to advance the discussion and development of public health and patient-centered health care. 

Leave a Reply